Lexicon Pharmaceuticals (LXRX) Change in Cash: 2009-2012
Historic Change in Cash for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to $9.7 million.
- Lexicon Pharmaceuticals' Change in Cash fell 93.80% to $9.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$155.9 million, marking a year-over-year decrease of 212.07%. This contributed to the annual value of $44.2 million for FY2024, which is 285.05% up from last year.
- As of Q4 2012, Lexicon Pharmaceuticals' Change in Cash stood at $9.7 million, which was up 174.22% from -$13.0 million recorded in Q3 2012.
- Lexicon Pharmaceuticals' Change in Cash's 5-year high stood at $159.6 million during Q1 2010, with a 5-year trough of -$164.8 million in Q4 2010.
- Moreover, its 3-year median value for Change in Cash was -$6.1 million (2010), whereas its average is -$5.8 million.
- In the last 5 years, Lexicon Pharmaceuticals' Change in Cash plummeted by 535.72% in 2010 and then skyrocketed by 2,170.95% in 2012.
- Over the past 4 years, Lexicon Pharmaceuticals' Change in Cash (Quarterly) stood at $37.8 million in 2009, then slumped by 535.72% to -$164.8 million in 2010, then spiked by 194.54% to $155.8 million in 2011, then plummeted by 93.80% to $9.7 million in 2012.
- Its Change in Cash was $9.7 million in Q4 2012, compared to -$13.0 million in Q3 2012 and $4.8 million in Q2 2012.